Dingdang Health executes HKD 0.87 million share buy-back; issued float slips 0.08 %

Bulletin Express10-15

Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 1.02 million ordinary shares on 15 October 2026 through on-exchange transactions. The shares were bought at prices ranging between HKD 0.84 and HKD 0.87, equivalent to a volume-weighted average cost of HKD 0.8559 per share. The total cash consideration amounted to HKD 0.87 million.

Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined 0.08 % to 1.23 billion shares, versus 1.23 billion on 14 October 2026. The company now holds 11.78 million shares in treasury, up from 10.76 million previously, representing about 0.95 % of total issued shares, which remain unchanged at 1.24 billion.

The buy-back was conducted under the general mandate approved on 23 June 2026 that authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate have reached 14.64 million shares, or 1.18 % of the issued share base at the time the mandate was granted, leaving substantial capacity for further action.

Under Hong Kong Stock Exchange rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 14 November 2026, 30 days after the latest repurchase. All regulatory filings and procedural requirements relating to the transaction have been duly completed, according to the company secretary’s confirmation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187231705?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-15 18:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187231705","market":"us","top_or_hot":-1,"title":"Dingdang Health executes HKD 0.87 million share buy-back; issued float slips 0.08 %","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 1.02 million ordinary shares on 15 October 2026 through on-exchange transactions. The shares were bought at prices ranging between HKD 0.84 and HKD 0.87, equivalent to a volume-weighted average cost of HKD 0.8559 per share. The total cash consideration amounted to HKD 0.87 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined 0.08 % to 1.23 billion shares, versus 1.23 billion on 14 October 2026. The company now holds 11.78 million shares in treasury, up from 10.76 million previously, representing about 0.95 % of total issued shares, which remain unchanged at 1.24 billion.</p>\n<p>The buy-back was conducted under the general mandate approved on 23 June 2026 that authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate have reached 14.64 million shares, or 1.18 % of the issued share base at the time the mandate was granted, leaving substantial capacity for further action.</p>\n<p>Under Hong Kong Stock Exchange rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 14 November 2026, 30 days after the latest repurchase. All regulatory filings and procedural requirements relating to the transaction have been duly completed, according to the company secretary’s confirmation.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health executes HKD 0.87 million share buy-back; issued float slips 0.08 %</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health executes HKD 0.87 million share buy-back; issued float slips 0.08 %\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-15 18:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 1.02 million ordinary shares on 15 October 2026 through on-exchange transactions. The shares were bought at prices ranging between HKD 0.84 and HKD 0.87, equivalent to a volume-weighted average cost of HKD 0.8559 per share. The total cash consideration amounted to HKD 0.87 million.</p>\n<p>Following the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined 0.08 % to 1.23 billion shares, versus 1.23 billion on 14 October 2026. The company now holds 11.78 million shares in treasury, up from 10.76 million previously, representing about 0.95 % of total issued shares, which remain unchanged at 1.24 billion.</p>\n<p>The buy-back was conducted under the general mandate approved on 23 June 2026 that authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate have reached 14.64 million shares, or 1.18 % of the issued share base at the time the mandate was granted, leaving substantial capacity for further action.</p>\n<p>Under Hong Kong Stock Exchange rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 14 November 2026, 30 days after the latest repurchase. All regulatory filings and procedural requirements relating to the transaction have been duly completed, according to the company secretary’s confirmation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1187231705","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187231705","pubTimestamp":1792060889,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 1.02 million ordinary shares on 15 October 2026 through on-exchange transactions. The shares were bought at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康执行87万港元股份回购；已发行流通量下滑 0.08%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed that it repurchased 1.02 million ordinary shares on 15 October 2026 through on-exchange transactions. The shares were bought at prices ranging between HKD 0.84 and HKD 0.87, equivalent to a volume-weighted average cost of HKD 0.8559 per share. The total cash consideration amounted to HKD 0.87 million.\nFollowing the transaction, Dingdang Health’s outstanding share count (excluding treasury shares) declined 0.08 % to 1.23 billion shares, versus 1.23 billion on 14 October 2026. The company now holds 11.78 million shares in treasury, up from 10.76 million previously, representing about 0.95 % of total issued shares, which remain unchanged at 1.24 billion.\nThe buy-back was conducted under the general mandate approved on 23 June 2026 that authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate have reached 14.64 million shares, or 1.18 % of the issued share base at the time the mandate was granted, leaving substantial capacity for further action.\nUnder Hong Kong Stock Exchange rules, Dingdang Health is restricted from issuing new shares or disposing of treasury shares until 14 November 2026, 30 days after the latest repurchase. All regulatory filings and procedural requirements relating to the transaction have been duly completed, according to the company secretary’s confirmation.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187231705","isCrawlerRequest":true}